(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue has been a limitation for determining EGFR mutation status in clinical practice. The objective of this study was to pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Guan, Jian, Xiao, Nan J., Chen, Min, Zhou, Wen L., Zhang, Yao W., Wang, Shuang, Dai, Yong M., Li, Lu, Zhang, Yue, Li, Qin Y., Li, Xiang Z., Yang, Mi, Wu, Hu B., Chen, Long H., Liu, Lai Y.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265876/
https://ncbi.nlm.nih.gov/pubmed/27472739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados